Crestline Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Crestline Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,452	Closed	-$2.58M	–	262
2018 Q2	$2.58M	Buy	18,452 +7,491	+68%	+$1.06M	0.27%	106
2018 Q1	$1.24M	Buy	+10,961	New	+$1.38M	0.15%	123

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crestline Management's GWPH Position: Q3 2018 in Review

Crestline Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2018, closing a stake of 18,452 shares — an estimated $2.58M sold.

Crestline Management first reported a position in GWPH in Q1 2018 and held it in 2 quarters. The position peaked at $2.58M in Q2 2018. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

Crestline Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
Crestline Management sold 18,452 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $2.58M.
Crestline Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 2 quarters.
Crestline Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.58M in Q2 2018.
272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.